Demonstration projects to show accurate use of artificial intelligence (AI) in cancer care are important to prevent a loss of credibility in the technology, explained Glenn Balasky, executive director, Rocky Mountain Cancer Centers.
While artificial intelligence (AI) has a lot of potential to transform care, if doctors feel like the information AI presents is not credible or accurate, they’ll lose confidence in the technology, said Glenn Balasky, executive director, Rocky Mountain Cancer Centers. He highlighted the need for experimentation and demonstration projects before AI is rolled out completely to prevent any loss in credibility that has doctors avoid using AI.
Balasky spoke at the annual Community Oncology Alliance Payer Exchange Summit on Oncology Payment Reform, September 9 to 10, in Reston, Virginia.
Transcript
What guardrails need to be in place in cancer care to ensure AI is used correctly and safely. How can community oncology practices toe the line of using AI for the benefit of patients and practices without running afoul of the downsides of AI use?
I think it's going to have to take some experimentation and demonstration projects, because I think there's 2 parts of it. We don't know what AI will tell us [and] we also don't know how our providers, our doctors, our teams, are going to respond to it. So, I think this is going to be both a learning curve as far as information, but [we] can’t underestimate the power. Doctors are in charge. They're accountable. Their medical license says that they're supposed to take care of the patient. If we present to them the first time [and] we show them something [clinical from AI] and it says something that's totally wrong, we're going to lose them, not for weeks, but for months, as far as credibility is concerned. So, I think the credibility of the information [is important]. Medicine is a field that's learned experienced [and] is always evolving, but we're going to have to meet our people where they are to make sure that this is a success.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Managed Care Reflections: A Q&A With Melinda B. Buntin, PhD
June 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The June issue features a conversation with Melinda B. Buntin, PhD, a health economist and a Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health and Carey Business School.
Read More
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
June 2nd 2025Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free survival (PFS) in HER2-positive breast cancer, potentially representing a new standard of care.
Read More